Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Contents - page 192
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study72
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France69
Editorial board62
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department49
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report47
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial39
Editorial board37
Contents37
Association between adipose deposition and mortality among adults without major cardiovascular risk factors35
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes35
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants33
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients32
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood31
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis31
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”30
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202130
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review29
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes28
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202028
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes27
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations26
Concise review of lipidomics in nonalcoholic fatty liver disease26
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes26
1-h post-load plasma glucose for detecting early stages of prediabetes25
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability25
Sommaire25
Contents25
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study24
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study23
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-201823
Type B insulin resistance syndrome: A case report21
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications20
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”20
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [Diabetes Metab 2021 Apr 13; 101251]20
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes20
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study19
Averaged glycaemic variability or by average: More than a simple question of wording19
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY318
Glucose management indicator: Do we need device-specific equations?18
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin18
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT18
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study17
Editorial board16
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease15
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study15
Contents - Page 115
Diabetes prevalence, awareness, and control in the United States, 2017-202315
Editorial board15
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction15
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes14
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach14
Transitions in metabolic health status over time and risk of heart failure: A prospective study14
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations14
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus14
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation14
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies13
Contents - page 113
Glucagon like peptide-1 receptor agonists in type 1 diabetes13
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention13
Contents13
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease12
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance11
Editorial board11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand11
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design11
Contents11
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus11
Diabetic ketoacidosis and mortality in COVID-19 infection10
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs10
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography10
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults10
Editorial board9
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists9
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan9
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States9
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION9
Editorial board8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study8
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial8
Editorial board8
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease8
0.12151503562927